NCT01404052

Brief Summary

The purpose of this study is to see the effects of transcranial direct current stimulation (tDCS) on the pain associated with osteoarthritis of the knee. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation. Before, during and after stimulation, the investigators will measure and assess changes intracranial blood flow with transcranial ultrasound.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2011

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 27, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2014

Completed
Last Updated

April 24, 2020

Status Verified

April 1, 2020

Enrollment Period

3.6 years

First QC Date

June 29, 2011

Last Update Submit

April 23, 2020

Conditions

Keywords

transcranial direct current stimulationtranscranial ultrasound

Outcome Measures

Primary Outcomes (1)

  • Changes in pain scale

    Determine whether anodal transcranial direct current stimulation in conjunction with transcranial ultrasound (applied in a diagnostic mode) is effective in reducing pain in subjects with chronic osteoarthritis pain, as measured by changes in the Visual Analogue Scale (VAS) for pain. VAS will be measured immediately before the tDCS stimulation sessions, and immediately after the tDCS stimulation sessions for the subject's duration in the trial. VAS will also be measured at baseline, and at three follow-up sessions after tDCS stimulation (up to 2 months after tDCS stimulation)

    Measured for approximately 2 months

Secondary Outcomes (2)

  • Changes in cutaneous allodynia/hyperalgesia

    Measured for approximately 2 months

  • Assessment of hemodynamic changes with transcranial ultrasound

    Measured for approximately 2 months

Study Arms (2)

Active tDCS + transcranial ultrasound

EXPERIMENTAL

Subjects will undergo 20 minutes active tDCS in conjunction with transcranial ultrasound measurements.

Device: Transcranial Direct Current Stimulation

Sham tDCS + transcranial ultrasound

SHAM COMPARATOR

Subjects will receive sham tDCS in conjunction with transcranial ultrasound measurements.

Device: Transcranial Direct Current Stimulation

Interventions

Subjects will be randomized to undergo either 5 sessions of active tDCS stimulation, or 5 sessions of sham tDCS stimulation. For both active and sham stimulation, we will use electrodes of 35cm\^2 and an intensity of 2mA. The anodal electrode will be placed over the primary motor cortex contralateral to the most painful side, and the cathodal electrode will be placed over the contralateral supraorbital area. Active stimulation will last for 20 minutes, while sham stimulation will only last for 30 seconds, mimicking the sensations during active stimulation.

Also known as: low intensity 1x1 direct current stimulator
Active tDCS + transcranial ultrasoundSham tDCS + transcranial ultrasound

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Providing informed consent to participate in the study
  • to 64 years old
  • Having chronic osteoarthritis knee pain in either knee (existing pain for more than 6 months with an average of at least 3 on a 0-10 VAS scale)
  • Pain resistant to common analgesics and medications for chronic pain such as Tylenol, Aspirin, Ibuprofen, Soma, Parafon Forte DCS, Zanaflex, and Codeine.
  • Must have the ability to feel pain as self reported

You may not qualify if:

  • Subject is pregnant.
  • Contraindications to tDCS:
  • metal in the head
  • implanted brain medical devices
  • Contraindications to TUS:
  • metal in the head
  • implanted brain medical devices
  • History of alcohol or drug abuse within the past 6 months as self reported
  • Use of carbamazepine within the past 6 months as self reported.
  • Suffering from severe depression (with a score of \>30 in the Beck Depression Inventory)
  • History of neurological disorders as self reported.
  • History of unexplained fainting spells as self reported,
  • History of head injury resulting in more than a momentary loss of consciousness as self reported
  • History of neurosurgery as self reported

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spaulding Rehabilitation Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Chronic PainOsteoarthritis

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Felipe Fregni, MD, PhD, MPH

    Spaulding Rehabilitation Hospital (SRH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 29, 2011

First Posted

July 27, 2011

Study Start

January 1, 2011

Primary Completion

July 30, 2014

Study Completion

July 30, 2014

Last Updated

April 24, 2020

Record last verified: 2020-04

Locations